Polyethylene glycol 3350 and electrolytes and Acute kidney failure - a phase IV clinical study of FDA data

Summary:

Acute kidney failure is reported only by a few people who take Polyethylene Glycol 3350 And Electrolytes.

The phase IV clinical study analyzes which people take Polyethylene glycol 3350 and electrolytes and have Acute kidney failure. It is created by eHealthMe based on reports of 48 people who have side effects while taking Polyethylene glycol 3350 and electrolytes from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Oct, 06, 2022

48 people reported to have side effects when taking Polyethylene glycol 3350 and electrolytes.
Among them, 3 people (6.25%) have Acute kidney failure.


What is Polyethylene glycol 3350 and electrolytes?

Polyethylene glycol 3350 and electrolytes has active ingredients of polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous. eHealthMe is studying from 48 Polyethylene glycol 3350 and electrolytes users for its effectiveness, alternative drugs and more.

What is Acute kidney failure?

Acute kidney failure is found to be associated with 3,700 drugs and 3,728 conditions by eHealthMe.

Number of Polyethylene glycol 3350 and electrolytes and Acute kidney failure reports submitted per year:

Could Polyethylene glycol 3350 and electrolytes cause Acute kidney failure?

Gender of people who have Acute kidney failure when taking Polyethylene glycol 3350 and electrolytes*:

Click here to view

Age of people who have Acute kidney failure when taking Polyethylene glycol 3350 and electrolytes *:

Click here to view

Common drugs people take besides Polyethylene glycol 3350 and electrolytes *:

Click here to view

Common side effects people have besides Acute kidney failure *:

Click here to view

Common conditions people have *:

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take Polyethylene glycol 3350 and electrolytes and have Acute kidney failure?

Check whether Acute kidney failure is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Acute kidney failure and when was it recovered:

Expand to all the drugs that have ingredients of polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous:

Alternative drugs to, pros and cons of Polyethylene glycol 3350 and electrolytes:

Acute kidney failure treatments and more:

COVID vaccines that are related to Acute kidney failure:

Common drugs associated with Acute kidney failure:

All the drugs that are associated with Acute kidney failure:

Common conditions associated with Acute kidney failure:

All the conditions that are associated with Acute kidney failure:

How the study uses the data?

The study uses data from the FDA. It is based on polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous (the active ingredients of Polyethylene glycol 3350 and electrolytes) and Polyethylene glycol 3350 and electrolytes (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: